Evidence map›Paper›PMID 39627504›Full record

ReviewJournal of anesthesia2025

Consensus statement on chronic pain treatment in cancer survivors.

Keiko Mamiya, Hiroki Iida, Masako Iseki, Shigeki Yamaguch, Hiroshi Yonekura, Hiroshi Ueno, Toshifumi Kosugi, Takeshi Sasara, Yumiko Takao, Toshifumi Takasusuki and 5 more

Erratum issuedAbstract readReviewConsensus Statement
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of anesthesia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Keiko MamiyaDivision of Palliative Medicine, Shinshu Cancer Center, Shinshu University Hospital, 3-1-1 Asahi, Matsumoto, 390-8621, Japan. keiko@shinshu-u.ac.jp.ORCID http://orcid.org/0000-0003-0074-3755
Hiroki IidaGifu University/Anesthesiology and Pain Relief Center, Central Japan International Medical Center, Minokamo, Japan.
Masako IsekiDepartment of Anesthesiology and Pain Medicine, Faculty of Medicine, Juntendo University, Bunkyō, Japan.
Shigeki YamaguchDepartment of Anesthesiology, Dokkyo Medical University School of Medicine, Mibu, Japan.
Hiroshi YonekuraDepartment of Anesthesiology and Pain Medicine, Fujita Health University Bantane Hospital, Nagoya, Japan.
Hiroshi UenoDepartment of Anesthesiology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Toshifumi KosugiDepartment of Palliative Care, Saga-Ken Medical Center Koseikan, Saga, Japan.
Takeshi SasaraYuuaikai Tomishiro Central Hospital, Total Pain Center, Tomigusuku, Japan.
Yumiko TakaoDepartment of Pain Medicine, Hyogo Medical University Hospital, Nishinomiya, Japan.
Toshifumi TakasusukiDepartment of Anesthesiology, Dokkyo Medical University School of Medicine, Mibu, Japan.
Saori HashiguchiDepartment of Palliative Medicine, St. Marianna University School of Medicine, Kawasaki, Japan.
Naomi HirakawaDepartment of Anesthesiology and Pain Clinic, Hirakawa Hospital, Tokyo, Japan.
Yoko SugiyamaGifu University/Anesthesiology and Pain Relief Center, Central Japan International Medical Center, Minokamo, Japan.
Keiko YamadaDepartment of Anesthesiology and Pain Medicine, Faculty of Medicine, Juntendo University, Bunkyō, Japan.
Kenji YamamotoDepartment of Palliative Care, Hokkaido Cancer Center, Hokkaido, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In September 2023, the Japan Society of Pain Clinicians (JSPC) issued this consensus statement on chronic pain treatment in cancer survivors. With recent advances in the early diagnosis and treatment of cancer, its prognosis has improved, so prolonged pain in cancer survivors is considered to represent chronic pain and should be addressed. In this statement, we emphasize that not all cancer survivor pain is cancer pain. Pain that is not cancer pain should be managed with analgesics other than opioids and nerve blocks, and pain that persists despite this approach should be treated as non-cancer chronic pain so as to prevent opioid overuse. In addition, cancer survivors at any stage of disease have a potentially life-threatening condition and constantly carry the fear of cancer recurrence. Therefore, even non-cancer pain should not be treated in the same way as general chronic pain, but should be managed with consideration of emotional distress. In the future, we plan to create educational tools for healthcare professionals and to conduct online seminars, both with the goal of providing cancer survivors with appropriate assessment and treatment of chronic pain.

Indexed as

Cancer PainCancer SurvivorsChronic PainNeoplasmsPain ManagementAnalgesics, OpioidConsensusHumansAnalgesics, OpioidCancer survivorsChronic painStatement

Identifiers

PMID39627504
PMCPMC11937162

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.